1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
641346282353E4068002588D9003E2274
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-biopharma-digital-launch-transformation-strategy-investment?opendocument
18
19opendocument
2034.236.191.0
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




» Products & Services » » Digital Technology » Digital Marketing Strategies

White Paper: Biopharma’s Digital Launch Transformation: Strategy and Investment

Whitepaper Image

ID: BEB-94


Pages/Slides: 7


Published: 2022


Delivery Format: PDF


 

License Options:


Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
While digital tactics were an auxiliary component of the overall biopharma launch strategy traditionally, the global pandemic of 2020 pushed organizations to fully integrate digital strategies into their launch models.

Now that digital approaches are an integral part of biopharma go-to-market strategies, many companies are implementing metrics to measure the effectiveness of investment in digital platforms.

Best Practices, LLC conducted benchmarking research – spotlighted in this white paper – to investigate the accelerated pace of digital adoption to drive innovative biopharma launches. The research spotlights high-value digital launch activities, probes secondary and tertiary drivers of digital acceleration in launch, identifies investment trends, and highlights the key lessons learned from new launches.

The findings and benchmarks examined in this white paper include:

  • Digital Activities and Acceleration
  • Digital Impact on a Successful Launch
  • Investment Trend and Effective Assessment
Industries Profiled:
Consulting; Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research; Communications


Companies Profiled:
Pharma; Biotech; Medical Device Companies